Literature DB >> 2178355

Use of baculovirus expression vectors: development of diagnostic reagents, vaccines and morphological counterparts of bluetongue virus.

P Roy1.   

Abstract

The productivity and flexibility of insect baculovirus expression vectors and the ability of the baculovirus genome to incorporate (and express) large amounts of foreign DNA allows this system to be used for both single and multiple gene expression. Using the system, bluetongue virus (BTV) genes have been expressed to develop diagnostic reagents and vaccines as well as to understand the basic structures of the virions. BTV which causes disease in ruminants in many parts of the world, consists of 10 double-stranded RNA segments enclosed by double capsids that are composed by 7 structural proteins. Since each protein is encoded by a single RNA species, DNA clones of all 10 RNA species were synthesized and individually expressed in baculovirus vectors at high levels. This has yielded proteins that have been shown to be excellent diagnostic and vaccine reagents. In addition, multiple expression vectors have been used to synthesize morphological structures (viral and subviral) representing BTV.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178355     DOI: 10.1111/j.1574-6968.1990.tb03523.x

Source DB:  PubMed          Journal:  FEMS Microbiol Immunol        ISSN: 0920-8534


  8 in total

1.  Biochemical analysis of MST1 kinase: elucidation of a C-terminal regulatory region.

Authors:  Ruchi Anand; Ah-Young Kim; Michael Brent; Ronen Marmorstein
Journal:  Biochemistry       Date:  2008-06-24       Impact factor: 3.162

2.  Baculovirus-expressed nonstructural protein NS2 of bluetongue virus induces a cytotoxic T-cell response in mice which affords partial protection.

Authors:  L D Jones; T Williams; D Bishop; P Roy
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Bluetongue virus viral protein 7 stability in the presence of glycerol and sodium chloride.

Authors:  Bonnie Leigh Russell; Samantha Gildenhuys
Journal:  Clin Exp Vaccine Res       Date:  2020-07-31

4.  Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig.

Authors:  Hye-Young Jeoung; Won-Ha Lee; WooSeog Jeong; Bo-Hye Shin; Hwan-Won Choi; Hee Soo Lee; Dong-Jun An
Journal:  Virol J       Date:  2011-04-15       Impact factor: 4.099

5.  Identification and differentiation of the twenty six bluetongue virus serotypes by RT-PCR amplification of the serotype-specific genome segment 2.

Authors:  Narender S Maan; Sushila Maan; Manjunatha N Belaganahalli; Eileen N Ostlund; Donna J Johnson; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

6.  The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS21-180) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge.

Authors:  Sergio Utrilla-Trigo; Luis Jiménez-Cabello; Eva Calvo-Pinilla; Alejandro Marín-López; Gema Lorenzo; Pedro Sánchez-Cordón; Sandra Moreno; Julio Benavides; Sarah Gilbert; Aitor Nogales; Javier Ortego
Journal:  J Virol       Date:  2021-11-17       Impact factor: 5.103

7.  Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2.

Authors:  Tamara Kusay Jabbar; Eva Calvo-Pinilla; Francisco Mateos; Simon Gubbins; Abdelghani Bin-Tarif; Katarzyna Bachanek-Bankowska; Oya Alpar; Javier Ortego; Haru-Hisa Takamatsu; Peter Paul Clement Mertens; Javier Castillo-Olivares
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

8.  Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR -/- mice.

Authors:  Petra C Fay; Houssam Attoui; Carrie Batten; Fauziah Mohd Jaafar; George P Lomonossoff; Janet M Daly; Peter P C Mertens
Journal:  Vaccine X       Date:  2019-06-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.